Clinical Research Directory

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Sponsor: Power Life Sciences Inc.

Summary

Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in hepatocellular carcinoma clinical research, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with hepatocellular carcinoma who may be invited to participate in clinical research in the years to come.

Official title: A Critical Analysis of Hepatocellular Carcinoma Trials: Perspectives From Patient Experiences

Key Details

Conditions